|
|
|
|
|
|
|
|
|
|
Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer
Wednesday, February 06, 2013
Subscribe to:
Post Comments
(
Atom
)
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
ovarian cancer
Ovarian Cancer Awareness (teal)
ovarian cancer
Ovarian Cancer
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.